Edition:
United Kingdom

Anixa Biosciences Inc (ANIX.OQ)

ANIX.OQ on NASDAQ Stock Exchange Capital Market

4.14USD
23 Aug 2019
Change (% chg)

$-0.12 (-2.82%)
Prev Close
$4.26
Open
$4.21
Day's High
$4.22
Day's Low
$4.06
Volume
3,728
Avg. Vol
14,746
52-wk High
$6.86
52-wk Low
$3.10

About

Anixa Biosciences, Inc. is a biotechnology company. The Company is developing a cancer immunotherapy program, which leverages chimeric endocrine receptor t-cell (CER-T) technology, and is engaged in developing a diagnostic platform called Cchek, for the early detection of tumor-based cancers. The Cchek liquid biopsy technology... (more)

Overall

Beta: 0.77
Market Cap(Mil.): $92.24
Shares Outstanding(Mil.): 20.10
Dividend: --
Yield (%): --

Financials

  ANIX.OQ Industry Sector
P/E (TTM): -- 98.31 33.85
EPS (TTM): -0.96 -- --
ROI: -293.85 7.52 12.69
ROE: -288.66 7.94 17.13
Reuters.com is improving our Quote page. Click here to take a look and let us know what you think.

Earnings vs. Estimates